I agree that this site is using cookies. You can find further informations here.
X
DePestel, Daryl D
69  results:
Search for persons X
?
1

Ceftolozane/tazobactam and imipenem/relebactam cross-suscep..:

Lob, Sibylle H ; DePestel, Daryl D ; DeRyke, C Andrew...
Open Forum Infectious Diseases.  , 2021
Link: https://doi.org/10.1093/..
 
?
2

Antimicrobial stewardship and antibiograms: importance of m..:

Klinker, Kenneth P. ; Hidayat, Levita K. ; DeRyke, C. Andrew...
Therapeutic Advances in Infectious Disease.  8 (2021)  - p. 204993612110113 , 2021
Link: https://doi.org/10.1177/..
 
?
3

Ceftolozane-tazobactam activity against clinical isolates o..:

Pfaller, Michael A. ; Shortridge, Dee ; Harris, Kelly A....
International Journal of Infectious Diseases.  112 (2021)  - p. 321-326 , 2021
Link: https://doi.org/10.1016/..
 
?
4

Epidemiology and regional variation of nonsusceptible and m..:

Puzniak, Laura ; DePestel, Daryl D. ; Yu, Kalvin..
Diagnostic Microbiology and Infectious Disease.  99 (2021)  2 - p. 115172 , 2021
Link: https://doi.org/10.1016/..
 
?
5

1450. Frequency of Carbapenem-resistant Pseudomonas aerugin..:

Klinker, Kenneth ; DePestel, Daryl ; Motyl, Mary.
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S727-S728 , 2020
Link: https://doi.org/10.1093/..
 
?
6

In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Ta..:

Karlowsky, James A ; Lob, Sibylle H ; Raddatz, Janet...
Clinical Infectious Diseases.  72 (2020)  12 - p. 2112-2120 , 2020
Link: https://doi.org/10.1093/..
 
?
7

Evaluation of Renal Safety Between Imipenem/Relebactam and ..:

Paschke, Amanda ; Butterton, Joan R ; DePestel, Daryl D...
Open Forum Infectious Diseases.  7 (2020)  3 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
8

1587. Activity of Ceftolozane/Tazobactam against Gram-Negat..:

Lob, Sibylle ; Hackel, Meredith ; DePestel, Daryl...
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S790-S791 , 2020
Link: https://doi.org/10.1093/..
 
?
9

Comparison of the In Vitro Susceptibility of Ceftolozane-Ta..:

Shortridge, Dee ; Pfaller, Michael A ; Arends, S J Ryan...
Open Forum Infectious Diseases.  6 (2019)  6 - p. , 2019
Link: https://doi.org/10.1093/..
 
?
10

597. Cross-resistance of Ceftolozane-Tazobactam and Imipene..:

Lob, Sibylle ; Kazmierczak, Krystyna ; DePestel, Daryl...
Open Forum Infectious Diseases.  6 (2019)  Supplement_2 - p. S281-S281 , 2019
Link: https://doi.org/10.1093/..
 
?
11

A Combination Antibiogram Evaluation forPseudomonas aerugin..:

Puzniak, Laura ; DePestel, Daryl D. ; Srinivasan, Arjun...
Antimicrobial Agents and Chemotherapy.  63 (2019)  4 - p. , 2019
Link: https://doi.org/10.1128/..
 
?
12

718. Activity of Ceftolozane–Tazobactam and Ceftazidime–Avi..:

Lob, Sibylle ; Kazmierczak, Krystyna ; Raddatz, Janet...
Open Forum Infectious Diseases.  6 (2019)  Supplement_2 - p. S323-S323 , 2019
Link: https://doi.org/10.1093/..
 
?
13

1951. Nephrotoxicity Associated With Imipenem/Cilastatin/Re..:

Brown, Michelle ; Motsch, Johann ; Kaye, Keith...
Open Forum Infectious Diseases.  5 (2018)  suppl_1 - p. S563-S563 , 2018
Link: https://doi.org/10.1093/..
 
?
14

Carbapenem-Nonsusceptible Gram-Negative Pathogens in ICU an..:

McCann, Eilish ; Srinivasan, Arjun ; DeRyke, C Andrew...
Open Forum Infectious Diseases.  5 (2018)  10 - p. , 2018
Link: https://doi.org/10.1093/..
 
?
15

Multidrug-Resistant Pseudomonas aeruginosa (MDR-PSA) in USA..:

Deryke, C. Andrew ; Depestel, Daryl D. ; Tabak, Ying P....
Open Forum Infectious Diseases.  3 (2016)  suppl_1 - p. , 2016
Link: https://doi.org/10.1093/..
 
1-15